rs375681665
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM1BP4_Strong
The NM_001371596.2(MFSD8):c.689C>T(p.Ala230Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000744 in 1,612,068 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001371596.2 missense
Scores
Clinical Significance
Conservation
Publications
- neuronal ceroid lipofuscinosisInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- neuronal ceroid lipofuscinosis 7Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, G2P
- macular dystrophy with central cone involvementInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001371596.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MFSD8 | NM_001371596.2 | MANE Select | c.689C>T | p.Ala230Val | missense | Exon 6 of 12 | NP_001358525.1 | ||
| MFSD8 | NM_001371591.2 | c.689C>T | p.Ala230Val | missense | Exon 6 of 12 | NP_001358520.1 | |||
| MFSD8 | NM_001371592.2 | c.695C>T | p.Ala232Val | missense | Exon 6 of 12 | NP_001358521.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MFSD8 | ENST00000641686.2 | MANE Select | c.689C>T | p.Ala230Val | missense | Exon 6 of 12 | ENSP00000493218.2 | ||
| MFSD8 | ENST00000296468.8 | TSL:1 | c.689C>T | p.Ala230Val | missense | Exon 7 of 13 | ENSP00000296468.3 | ||
| MFSD8 | ENST00000641186.1 | c.575C>T | p.Ala192Val | missense | Exon 5 of 11 | ENSP00000493347.1 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152030Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000120 AC: 3AN: 250620 AF XY: 0.0000148 show subpopulations
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1460038Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 726348 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152030Hom.: 0 Cov.: 31 AF XY: 0.0000539 AC XY: 4AN XY: 74248 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Late-infantile neuronal ceroid lipofuscinosis Uncertain:1
Neuronal ceroid lipofuscinosis 7 Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 230 of the MFSD8 protein (p.Ala230Val). This variant is present in population databases (rs375681665, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with MFSD8-related conditions. ClinVar contains an entry for this variant (Variation ID: 533371). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The valine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at